Upgrades And Downgrades For Applied Genetic Technologies Corporation (AGTC)
Recently stock market analysts have updated their consensus ratings on shares of Applied Genetic Technologies Corporation (AGTC). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.
Most recent broker ratings
04/11/2016 – BMO Capital Markets began new coverage on Applied Genetic Technologies Corporation giving the company a “outperform” rating. They now have a USD 25 price target on the stock.
03/18/2016 – Janney Montgomery Scott began new coverage on Applied Genetic Technologies Corporation giving the company a “buy” rating. They now have a USD 23 price target on the stock.
02/09/2016 – Applied Genetic Technologies Corporation had its “buy” rating reiterated by analysts at Stifel Nicolaus. They now have a USD 29 price target on the stock.
12/11/2015 – Applied Genetic Technologies Corporation had its “buy” rating reiterated by analysts at Cantor Fitzgerald. They now have a USD 32 price target on the stock.
12/03/2015 – Wells Fargo began new coverage on Applied Genetic Technologies Corporation giving the company a “outperform” rating.
09/11/2015 – Applied Genetic Technologies Corporation had its “outperform” rating reiterated by analysts at Wedbush. They now have a USD 36 price target on the stock.
09/11/2015 – Applied Genetic Technologies Corporation had its “buy” rating reiterated by analysts at Roth Capital. They now have a USD 34 price target on the stock.
07/22/2015 – Chardan Capital began new coverage on Applied Genetic Technologies Corporation giving the company a “buy” rating. They now have a USD 25 price target on the stock.
04/30/2015 – Applied Genetic Technologies Corporation had its “hold” rating reiterated by analysts at Zacks.
Applied Genetic Technologies Corporation has a 50 day moving average of 15.56 and a 200 day moving average of 15.45. The stock’s market capitalization is 257.21M, it has a 52-week low of 10.89 and a 52-week high of 21.43.
The share price of the company (AGTC) was down -1.11% during the last trading session, with a high of 14.61 and the volume of Applied Genetic Technologies Corporation shares traded was 152245.
View other investors thoughts on Applied Genetic Technologies Corporation on our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.

